Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia After Amputation in Rats Treated With Heparin, Warfarin, L-NAME and L-Arginine
Dispatched Tuesday and Friday in secure isothermal packaging, delivered within 2 to 3 days
By purchasing, you confirm that these compounds will be used solely for approved in vitro or pre-clinical research purposes
Unlike conventional treatments that temporarily mask pain signals, peptide therapy aims to address the underlying biological processes driving the condition
Within laboratory contexts, AOD9604 is used as a tool peptide to examine metabolic signaling mechanisms under defined conditions
Compounded preparations of AOD-9604 are not lawfully available in the United States as of the date of this listing, and the same restriction position applies under Health Canada's regulatory framework, where no authorized AOD-9604 product exists in any compounding category
US$ 24.37
US$ 27.69
US$ 20.75
US$ 22.12
US$ 27.59
US$ 27.74
.webp)
US$ 24.91
US$ 27.18
